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o r i g i n a l a r t i c l e
A Central Line Care Maintenance Bundle for the Prevention of
Central Line–Associated Bloodstream Infection in Non–Intensive
Care Unit Settings
Caroline O’Neil, MA, MPH;1 Kelly Ball, RN, MPH;1 Helen Wood, RN, CIC;2 Kathleen McMullen, MPH, CIC;2
Pamala Kremer, RN, CIC;2 S. Reza Jafarzadeh, DVM, MPVM, PhD;1 Victoria Fraser, MD;1 David Warren, MD, MPH1
objective. To evaluate a central line care maintenance bundle to reduce central line–associated bloodstream infection (CLABSI) in
non–intensive care unit settings.
design. Before-after trial with 12-month follow-up period.
setting. A 1,250-bed teaching hospital.
participants. Patients with central lines on 8 general medicine wards. Four wards received the intervention and 4 served as controls.
intervention. Amultifaceted catheter care maintenance bundle consisting of educational programs for nurses, update of hospital policies,
visual aids, a competency assessment, process monitoring, regular progress reports, and consolidation of supplies necessary for catheter
maintenance.
results. Data were collected for 25,542 catheter-days including 43 CLABSI (rate, 1.68 per 1,000 catheter-days) and 4,012 catheter dressing
observations. Following the intervention, a 2.5%monthly decrease in the CLABSI incidence density was observed on intervention ﬂoors but this
was not statistically signiﬁcant (95% CI, −5.3% to 0.4%). On control ﬂoors, there was a smaller but marginally signiﬁcant decrease in CLABSI
incidence during the study (change in monthly rate, −1.1%; 95% CI, −2.1% to −0.1%). Implementation of the bundle was associated with
improvement in catheter dressing compliance on intervention wards (78.8% compliance before intervention vs 87.9% during intervention/
follow-up; P< .001) but improvement was also observed on control wards (84.9% compliance before intervention vs 90.9% during
intervention/follow-up; P= .001).
conclusions. Amultifaceted program to improve catheter care was associated with improvement in catheter dressing care but no change in
CLABSI rates. Additional study is needed to determine strategies to prevent CLABSI in non–intensive care unit patients.
Infect Control Hosp Epidemiol 2016;37:692–698
Central line–associated bloodstream infections (CLABSI) are
common healthcare-associated infections that can lead to
longer hospital stays and increased healthcare costs.1,2
Improved central line insertion practices have led to reduc-
tions in CLABSI rates in intensive care units (ICUs), but a
substantial number of CLABSI occur among patients in
non-ICU inpatient wards.3 Of an estimated 250,000 CLABSI
that occur in US hospitals annually, only approximately 80,000
occur in ICUs.4 Increased recognition of the problem of
CLABSI outside of ICUs has led hospitals to expand CLABSI
surveillance to non-ICU settings.
Central lines are commonly used outside ICUs. Although
the proportion of patients with central lines is generally lower
in non-ICU wards than in ICUs, the total number of non-ICU
patients with central lines in any given hospital is often
higher.5–7 In addition, many patients in non-ICU settings have
central lines in place for prolonged periods, which supports the
use of interventions to improve central line use and main-
tenance practices as a means to prevent infection.8 Reported
CLABSI rates in non-ICU settings range from 2 to 6 per 1,000
line-days,7–14 which is similar to rates observed in ICUs before
implementation of interventions to reduce CLABSI.10
Adherence to best practices for central line care after inser-
tion is a well-established method to prevent CLABSI. Several
organizations have noted the importance of central line
maintenance practices in CLABSI prevention and have
recommended that central line care be a focus of performance
improvement and quality assurance in all programs.15,16
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Nationally published guidelines provide speciﬁc catheter care
recommendations, including education of healthcare person-
nel responsible for catheter maintenance; disinfection of hubs,
needleless connectors, and injection ports before catheter
access; use of chlorhexidine skin preparation with alcohol for
skin antisepsis; and routinely changing transparent dressings
every 5–7 days and gauze dressings every 2 days or whenever
soiled, loose, or damp.15–17 Yet, despite recognition of the
importance of central line maintenance in relation to CLABSI
prevention, adherence to best practices may be inadequate in
non-ICU wards, which have not generally been included in
CLABSI prevention efforts.6
The purpose of this study was to develop, implement, and
evaluate a central line care maintenance bundle designed to
optimize central line maintenance practices and reduce
CLABSI in non-ICU settings at a large, academic medical
center. Prior studies have demonstrated the effectiveness of
bundled educational and behavioral interventions in improv-
ing compliance with recommended catheter care practices and
reducing CLABSI incidence.18–24 However, most of these
studies have focused exclusively on ICUs. We hypothesized
that similar bundled interventions might reduce CLABSI
incidence in non-ICU settings.
methods
Setting and Design
This before-after study with control group was conducted at
Barnes-Jewish Hospital, a 1,250-bed urban tertiary care academic
medical center. The study included all adult inpatients in
8 general medicine wards who had central lines in place for 1 or
more days from July 1, 2012, through December 31, 2013. There
were no exclusion criteria. Four wards were randomly selected
to receive the intervention and 4 wards served as controls.
Intervention and control wards had separate nursing leadership
and staff nurses did not rotate between wards.
CLABSI prevention policies at Barnes-Jewish Hospital
follow nationally published guidelines and emphasize proper
dressing change procedure, chlorhexidine skin antisepsis,
disinfection of catheter hubs/needleless connectors/injection
ports prior to access, and daily reassessment of the need for
continued central line access.1 Education and training on
central line care policies and procedures is provided to staff on
an annual basis.
Intervention
A multifaceted, central line care maintenance bundle was
developed focusing on maximizing aseptic technique for
accessing catheters for blood draws and medication/ﬂuid
administration. The intervention bundle consisted of educa-
tional programs for nurses emphasizing catheter/dressing care;
enhancement of hospital catheter-care policies; visual aids
illustrating proper catheter care techniques, including
accessing hubs; competency assessment; process monitoring;
and consolidation/standardization of the supplies necessary
for optimal central line maintenance into a convenient
package located in a standard location on the study wards.
Key components of the bundle included photo slides with
pictures showing proper procedure for changing catheter
dressings and regular feedback of data summarizing direct
observations of catheter dressings and insertion sites for ward
patients. Other measures associated with CLABSI prevention
(ie, hand hygiene observations and training on catheter
insertion practices) were already in place throughout the
hospital before the start of the study.
The intervention bundle was implemented between
October and December 2012. A 3-month preintervention
period (July-September, 2012) preceded bundle implementa-
tion and was used to establish baseline catheter care practices
and CLABSI rates. We collected data for the 12 months
following the intervention period to determine the impact of
the intervention once it had been fully implemented.
Data Collection
Patients with central lines were identiﬁed using hospital
electronic medical records. Demographic and hospitalization
data were also abstracted from electronic records, including
age, race, sex, dates of hospital admission, and catheter start
and end dates. For patients who had catheter-days on more
than 1 study ward during their admission, the total number of
catheter-days on intervention and control wards was calcu-
lated. Pharmacy records were used to determine the use of
chemotherapy (all antineoplastic agents excluding hydro-
xyurea) and corticosteroids (ie, prednisone, hydrocortisone, or
dexamethasone). Laboratory data were used to identify
patients with neutropenia (ie, absolute neutrophil count <500
cells/microliter).
Throughout the study period, trained research assistants
conducted twice weekly observations of existing central line
dressings on each study ward. Observations were standardized
and included whether the dressing was secured and intact;
whether the dressing was clean and dry; whether the dressing
was expired (48 hours for gauze dressings, 7 days for trans-
parent); whether there was purulent discharge; whether the
central line was secured; and whether the dressing was dated
(date written on the dressing or recorded in the electronic
medical record). These measures were used to calculate an
overall dressing compliance score, with observations that
met all 6 criteria being labeled as 100% compliant.
Reports summarizing dressing observation data and
CLABSI rate data were regularly shared with staff on inter-
vention wards as part of the intervention. These reports
included data for each intervention ward and the combined
data from all 4 intervention wards. Reports were shared with
staff at monthly meetings during the intervention period and
given to the nursing managers on each intervention ward every
2 months during the follow-up period.
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Incident CLABSI data were collected via the hospital’s
automated Non-ICU CLABSI Surveillance system.25 The
Non-ICU CLABSI Surveillance system applies an algorithm to
electronic patient and microbiology data to identify CLABSI
in non-ICU wards. The algorithm identiﬁes positive blood
cultures that are hospital-acquired (occur ≥48 hours after
admission); positive for a noncommon skin contaminant;
associated with a patient who had a central line in place in the
48 hours before the culture; and not associated with a positive
culture of the same organism from another body site.25 A study
comparing the Non-ICU CLABSI Surveillance algorithm to
manual medical chart review using National Healthcare Safety
Network deﬁnitions to identify CLABSI determined that the
Non-ICU CLABSI Surveillance system had 95% sensitivity
and 97% speciﬁcity.25
CLABSI were attributed to the ward where the patient was
hospitalized at the time of infection. Infections were labeled
early CLABSI if they occurred less than 14 days after the ﬁrst
recorded catheter-day; infections that occurred 14 or more
days after line insertion were labeled late-onset CLABSI. This
cutoff was based on the observation that intraluminal con-
tamination increases after a catheter is in place for 2 weeks.26
Microbiologic data were obtained for each CLABSI to identify
microbiologic etiology. Catheter-day denominator data
were abstracted from medical informatics using midnight
census data.
The study protocol was reviewed and approved by the
Washington University Human Research Protection Ofﬁce.
The need for written informed consent was waived because
this was a quality improvement project.
Analysis
The characteristics of patients on intervention vs control wards
were compared using χ2 and t tests. Central line duration for
intervention vs control wards and for patients who did vs did
not develop CLABSI was compared using Mann-Whitney
tests. Monthly device utilization ratios (catheter-days/patient-
days) were calculated to identify potential differences in use of
central lines over time. Dressing observation data from the
preintervention period vs the combined intervention/follow-
up period were compared using χ2 tests to evaluate the impact
of the intervention bundle on catheter care practices. CLABSI
incidence densities were calculated for the combined inter-
vention and control wards, both before intervention and
during intervention/follow-up. The effect of the intervention
on the monthly CLABSI rate was evaluated using regression
models with autoregressive integrated moving average errors,
to account for the autocorrelation of errors over time.27
Microbiology data were evaluated to identify the types of
organisms associated with CLABSI. The proportion of early vs
late CLABSI during the preintervention vs intervention/
follow-up periods was compared using Fisher exact tests. Data
were analyzed using SPSS Statistics, version 21.0 (IBM), and
R Statistical Software, version 3.2.3 (R Core Team).
results
There were 25,542 catheter-days associated with 5,054
admissions during the study period; 13,394 catheter-days
occurred on intervention wards and 12,148 on control wards.
There were 4,410 catheter-days during the preintervention
period, 4,249 during the intervention period, and 16,883
during the follow-up period. Forty-three CLABSI were iden-
tiﬁed, 26 (60.5%) on intervention wards and 17 (39.5%) on
control wards. Ten CLABSI occurred during the preinterven-
tion period, 6 during the intervention period, and 27 during
follow-up. Eighteen infections (41.9%) were classiﬁed as
late-onset CLABSI.
There were no signiﬁcant differences in patient demo-
graphic characteristics or in chemotherapy or corticosteroid
use for patients on intervention vs control wards (Table 1).
The median number of catheter-days per admission was 3 for
both intervention and control wards (P= .085) and remained
stable throughout the study period (data not shown). The
device utilization ratio was also similar for intervention and
control wards (0.31 for intervention ﬂoors and 0.32 for control
ﬂoors) and remained stable throughout the study (0.30 before
the intervention vs 0.31 during/after the intervention on the
intervention wards and 0.32 both before and during/after the
intervention on the control wards).
Males were more likely to develop CLABSI than females
(60.5% of CLABSI patients were male vs 44.0% of non-
CLABSI patients; P= .031) (Table 2). Patients who developed
CLABSI also had a longer median duration of catheterization
than patients who did not develop CLABSI (10 vs 3 days;
P< .001).
A total of 4,012 central line dressing observations were made
for the study: 801 during the preintervention period, 579
during the intervention period, and 2,632 during the follow-up
period. Approximately 55% of observed lines were single- or
double-lumen peripherally inserted central catheters.
table 1. Comparison of Patient Demographic Characteristics by
Intervention Status in Study of Use of Central Line Care Maintenance
Bundle to Reduce Central Line–Associated Bloodstream Infection in







wards (n= 2,738) P
Female sex 1,331 (54.7%) 1,556 (56.8%) .129
Race .185
White 1,332 (54.8%) 1,439 (52.6%)
Black 926 (38.1%) 1,111 (40.6%)
Other/unknown 174 (7.2%) 188 (6.9%)
Age, mean (SD), y 55.5 (17.1) 54.9 (16.7) .212
Neutropenia 67 (2.8%) 56 (2.0%) .095
Chemotherapy 161 (6.6%) 163 (6.0%) .323
Corticosteroids 597 (24.5%) 694 (25.3%) .508
Line days per admission, median
(interquartile range)
3 (2–6) 3 (2–6) .085
NOTE. Data are no. (%) of patients unless otherwise indicated.
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The remainder were triple-lumen nontunneled central lines or
dialysis catheters. There was no signiﬁcant difference in the
proportion of peripherally inserted central catheters on
the intervention vs control wards (54.1% vs 56.1%; P= .183).
The results of the dressing observations is shown in Table 3.
The proportion of dressings observed to be 100% compliant
(meeting all 6 compliance measures) was higher on control
wards than on intervention wards during the preintervention
period (84.9% vs 78.8%; P= .026) and remained higher during
the intervention/follow-up period (90.9% vs 87.9%; P= .007).
On intervention wards, the proportion of dressings achieving
100% compliance increased from 78.8% before intervention to
87.9% during intervention/follow-up (difference, +9.1%;
P< .001) (Figure 1). However, dressing compliance on control
wards also improved during the study period, with the pro-
portion of 100% compliant dressings increasing from 84.9%
before intervention to 90.9% during intervention/follow-up
(difference, +6.0%; P= .001).
On the intervention wards, the preintervention CLABSI
incidence density was 3.02 per 1,000 catheter-days vs 1.72
per 1,000 catheter-days during/after the intervention
(incidence rate ratio, 0.57). On the control wards, CLABSI
incidence was 1.43 per 1,000 catheter-days before the inter-
vention vs 1.39 per 1,000 catheter-days during/after the
intervention (incidence rate ratio, 0.97) (Figure 2). Auto-
regressive integrated moving average analysis indicated that,
during the study period, the monthly CLABSI incidence
density decreased at a rate of 2.5% per month on the inter-
vention ﬂoors (−2.5% [95% CI, −5.3% to 0.4%]), though this
decrease was not statistically signiﬁcant. On control ﬂoors,
the monthly CLABSI rate decreased at a rate of 1.1% (−1.1%
[95% CI, −2.1% to −0.1%]), which was marginally signiﬁcant.
There was no statistically signiﬁcant difference in mean
CLABSI incidence rates for the intervention vs control wards
during the preintervention period (incidence rate ratio,
2.10 [95% CI, 0.56–7.89]) or during the intervention/follow-
up period (incidence rate ratio, 1.23 [95% CI, 0.62–2.45]).
For the CLABSI that occurred during the study period, the
types of organisms identiﬁed upon microbiologic analysis
included gram-positive aerobes (37.7%), gram-negative
table 2. Comparison of Patients by Central Line–Associated
Bloodstream Infection (CLABSI) Status in Study of Use of Central







Female sex 2,870 (56.0%) 17 (39.5%) .031
Race .131
White 2,749 (53.6%) 22 (51.2%)
Black 2,016 (39.3%) 21 (48.8%)
Other/unknown 362 (7.1%) 0
Age, mean (SD), y 55.2 (16.9) 53.0 (15.6) .734
Neutropenia 123 (2.4%) 0 .304
Chemotherapy 322 (6.3%) 2 (4.7%) .661
Corticosteroids 1,278 (24.9%) 13 (30.2%) .423
Line days per admission, median
(interquartile range)
3 (2–6) 10 (7–17) <.001
NOTE. Data are no. (%) of patients unless otherwise indicated.
table 3. Comparison of Dressing Observations, by Period and Intervention Status, in Study of Use of Central Line Care Maintenance
















Intervention wards (2,091 observations)
Preintervention 384 (86.7%) 409 (92.3%) 443 (100%) 429 (96.8%) 424 (95.7%) 438 (98.9%) 349 (78.8%)
Intervention/follow-up 1,540 (93.4%) 1,602 (97.2%) 1,639 (99.5%) 1,610 (97.7%) 1,623 (98.5%) 1,635 (99.2%) 1,449 (87.9%)
P valueb <.001 <.001 .119 .305 <.001 .492 <.001
Control wards (1,921 observations)
Preintervention 329 (91.9%) 344 (96.1%) 356 (99.4%) 354 (98.9%) 349 (97.5%) 354 (98.9%) 304 (84.9%)
Intervention/ follow-up 1,492 (95.5%) 1,517 (97.1%) 1,548 (99.0%) 1,553 (99.4%) 1,539 (98.5%) 1,554 (99.4%) 1,420 (90.9%)
P valueb .006 .342 .465 .338 .199 .260 .001
aComposite score incorporating all 6 of the individual dressing quality measures; dressings observed to have 6 of 6 measures compliant were
deﬁned as being 100% compliant.
bComparison of preintervention to intervention/follow-up period.
ﬁgure 1. Proportion of central line insertion sites/dressings that
were 100% compliant (6/6 measures) for the combined intervention
and control wards.
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aerobes (31.9%), anaerobes (15.9%), and fungi (13.0%).
There was no association between early vs late CLABSI status
and the types of organisms identiﬁed (P= .651). Eighteen
CLABSI (41.9%) were polymicrobial. The proportion of
CLABSI that was late-onset in the preintervention period vs
the intervention/follow-up period was similar in the inter-
vention wards (4/7 [57.1%] vs 9/19 [47.4%]; P> .99) and in
the control wards (0/3 [0%] vs 5/14 [35.7%]; P= .515).
discussion
We found that implementation of the central line care main-
tenance bundle was associated with improved insertion site
care on both intervention and control wards. The intervention
was also associated with a decrease in CLABSI incidence on the
intervention ﬂoors, although this decrease was not statistically
signiﬁcant, and a smaller but marginally signiﬁcant decrease
on control wards.
The dressing observation data revealed gaps in catheter care
practices on both intervention and control wards. Problems
with improperly dated or undated dressings have been repor-
ted in other studies of catheter care practices.28 In the survey of
nurses that we conducted to inform this study, nurses
frequently mentioned undated dressings as being a barrier to
performing dressing changes (data not shown). Further work
is needed to facilitate accurate recording of dressing changes
and to integrate reminders into electronic medical record
systems.
We also found that baseline compliance with optimal
dressing care practices was higher on control wards than on
intervention wards. In addition, while there was a 9.1%
improvement in compliance on intervention wards between
the preintervention and intervention/follow-up periods, there
was a 6.0% improvement in compliance on control wards over
the same periods. This indicates that larger secular trends in
improved dressing care hospital-wide may potentially account
for some of the observed improvement. Overall baseline
compliance with optimal dressing care practices was high on
both intervention and control wards even at baseline (78.8%
and 84.9%, respectively). This is in contrast to previous
observational studies at other teaching hospitals, where dres-
sing and insertion site care noncompliance was reported to be
31%–44.8%.28,29
Improvement in catheter care practices on intervention
wards following introduction of the central line care main-
tenance bundle was correlated with a 43% decrease in CLABSI
on intervention ﬂoors; however, this decrease did not achieve
statistical signiﬁcance. There was a smaller but marginally
signiﬁcant decrease in the CLABSI rate on control wards, along
with improvement in catheter care practices during the study
period. It is possible that, because compliance with catheter
care practices in these wards was already high at baseline, the
impact of further improvements was minimized. It is also
possible that hub disinfection practices did not change in
response to the intervention, reducing the impact on CLABSI
incidence. However, it is also possible that the observation
period was too short to detect a signiﬁcant change in rates over
time, especially because the rates in some wards were zero over
some months. Further study is needed to determine why better
catheter maintenance did not lead to lower CLABSI rates.
Examination of microbiology data identiﬁed gram-positive
and gram-negative aerobes as the most common sources of
infection for the CLABSI identiﬁed during the study period,
with many patients having multiple organisms identiﬁed upon
blood culture. There was no statistical difference in the
proportion of CLABSI that were late-onset during the
preintervention vs intervention/follow-up periods on either
intervention or control wards. However, the small number
of CLABSI patients in this sample would have made any
differences difﬁcult to detect.
In our study population, patients with central lines who
developed CLABSI were more likely to be male and had longer
average catheter duration than patients with central lines
who did not develop CLABSI. Male sex has previously been
identiﬁed as a risk factor for catheter-related BSI in studies
involving ICU patients,30,31 and longer catheter duration is
well known to increase risk for CLABSI owing to extended
exposure to risk.26,32
Strengths of this study include a focus on CLABSI preven-
tion in non-ICU settings, direct observation of catheter
insertion site care practices, and detailed microbiology data.
The main limitation of this study was the small number of
patients who developed CLABSI, which made it difﬁcult to
determine the impact of the central line care maintenance
bundle on CLABSI incidence.
ﬁgure 2. Central line–associated bloodstream infection
(CLABSI) rates over time by intervention status for the combined
intervention and control wards, with mean rate by study period.
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Reduction of CLABSI incidence within ICUs in the United
States over the past decade has been a major success in the ﬁeld
of healthcare-associated infection prevention.33 Translation of
these beneﬁts to patients outside the ICU is needed. Additional
studies are still needed to determine the optimal strategy to
make this occur.
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